• Bay Area Times
  • Posts
  • OpenAI said to delay IPO to 2027 amid doubts over Sam Altman’s $1T valuation goal

OpenAI said to delay IPO to 2027 amid doubts over Sam Altman’s $1T valuation goal

Brought to you by

Top stories today:

  1. OpenAI delays IPO to 2027 amid doubts over $1T valuation goal
  2. Apple -6% after raising Mac, iPad prices up to 25%
  3. Google seeks broad AI training rights from publishers
  4. Codex reaches 97.9% employee adoption at OpenAI
  5. General Intuition raises $320M at $2.3B valuation for spatial AI agents
  6. U.S. PCE inflation +4.1% YoY in May, most since Apr. 2023

0. Data and calendar

All values as of 6 AM ET / 3 AM PT, other than S&P500 and NASDAQ close (4 PM ET / 1 PM PT).

All times are ET.

Listen to our AI-generated podcast summarizing today’s newsletter (beware of hallucinations):

1. OpenAI said to delay IPO to 2027 amid doubts over Sam Altman’s $1T valuation goal

Altman reportedly pushed for a $1T public valuation, up from OpenAI’s last private valuation of $825B:

  • Q3-Q4: OpenAI had eyed an IPO after hiring bankers and lawyers.

  • OpenAI advisers warned a $1T IPO may struggle to attract retail investors in current market conditions.

  • Wait until 2027 to go public at a $1T valuation or lower the target for an earlier IPO, advisers reportedly suggested.

  • A lower valuation was a nonstarter, Altman reportedly responded.

SoftBank stock -13%, most since Aug. 2024, on the report of OpenAI’s IPO delay

Separately, the Trump admin reportedly asked OpenAI to stagger GPT-5.6’s rollout over security concerns

  • Altman informed staff about the update on Thu. after saying on Wed. that GPT-5.6 would get a limited release to a small group of partners.

  • The U.S. government would be “approving access customer by customer” during the preview period, he said.

  • Howard Lutnick reportedly cautioned OpenAI against launching GPT-5.6 before securing broader agency approvals.

  • Altman still hopes a general GPT-5.6 release will come a “couple of weeks later” if all goes well.

  • The best investors know small problems compound fast. Eye bags and tired skin are no different. You need to address them early, before they become the new normal.

  • That’s why Particle Anti-Aging Face Cream sold out so quickly once founders and investors discovered it. More than 1 million men now use it to combat eye bags, wrinkles, and dark spots. The 6-in-1 formula combines 12 high-grade ingredients in a single anti-aging solution built for men.

  • If you want that sharper, younger look that signals energy, discipline, and confidence, this is the move. Bay Area Times readers: Use code BAY20 for 20% off and free shipping before it sells out again.

*Sponsored.

3. Apple -6% after raising Mac, iPad prices up to 25%

Apple stock had its worst drop since Apr. 2025 after the price hike announcement:

*Sponsored.

5. Google said to seek broad AI training rights from publishers

Subscribe to keep reading

This content is free, but you must be subscribed to Bay Area Times to continue reading.

Already a subscriber?Sign in.Not now